FBIOP
Price:
$5.12
Market Cap:
$44.44M
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; MB-107 and MB-207 for the ...[Read more]
Industry
Biotechnology
IPO Date
2017-11-14
Stock Exchange
NASDAQ
Ticker
FBIOP
According to Fortress Biotech, Inc.’s latest financial reports and current stock price. The company's current ROE is -240.30%. This represents a change of 300.12% compared to the average of -60.06% of the last 4 quarters.
The mean historical ROE of Fortress Biotech, Inc. over the last ten years is -616.16%. The current -240.30% ROE has changed -61.00% with respect to the historical average. Over the past ten years (40 quarters), FBIOP's ROE was at its highest in in the March 2019 quarter at 6.69%. The ROE was at its lowest in in the December 2018 quarter at -1343.41%.
Average
-616.16%
Median
-147.40%
Minimum
-4543.57%
Maximum
-28.91%
Discovering the peaks and valleys of Fortress Biotech, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.47%
Maximum Annual ROE = -28.91%
Minimum Annual Increase = -95.65%
Minimum Annual ROE = -4543.57%
Year | ROE | Change |
---|---|---|
2023 | -268.97% | -47.54% |
2022 | -512.72% | 238.05% |
2021 | -151.67% | 47.77% |
2020 | -102.64% | -48.07% |
2019 | -197.63% | -95.65% |
2018 | -4543.57% | 3.47% |
2017 | -127.21% | -11.12% |
2016 | -143.12% | 68.00% |
2015 | -85.19% | 194.71% |
2014 | -28.91% | -36.77% |
The current ROE of Fortress Biotech, Inc. (FBIOP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-311.12%
5-year avg
-246.73%
10-year avg
-616.16%
Fortress Biotech, Inc.’s ROE is less than Checkpoint Therapeutics, Inc. (0%), less than Mustang Bio, Inc. (359.97%), less than Reviva Pharmaceuticals Holdings, Inc. (429.53%), less than Kodiak Sciences Inc. (664.92%), greater than Fortress Biotech, Inc. (-84.52%), greater than Achilles Therapeutics plc (-240.30%), greater than Aptose Biosciences Inc. (-54.57%), less than Indaptus Therapeutics, Inc. (1.03%), greater than Rezolute, Inc. (-177.27%), greater than Tempest Therapeutics, Inc. (-69.83%), greater than Comera Life Sciences Holdings, Inc. (-187.44%), less than Forte Biosciences, Inc. (67.46%), greater than Cyteir Therapeutics, Inc. (-151.43%), greater than XOMA Corporation (-9.44%), greater than Protagenic Therapeutics, Inc. (-33.68%), greater than null (-308.96%),
Company | ROE | Market cap |
---|---|---|
0% | $180.50M | |
359.97% | $9.63M | |
429.53% | $38.12M | |
664.92% | $325.74M | |
-84.52% | $44.44M | |
-240.30% | $43.57M | |
-54.57% | $3.71M | |
1.03% | $10.20M | |
-177.27% | $284.50M | |
-69.83% | $39.52M | |
-187.44% | $9.22K | |
67.46% | $23.39M | |
-151.43% | $108.71M | |
-9.44% | $353.53M | |
-33.68% | $4.42M | |
-308.96% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fortress Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Fortress Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Fortress Biotech, Inc.'s ROE?
How is the ROE calculated for Fortress Biotech, Inc. (FBIOP)?
What is the highest ROE for Fortress Biotech, Inc. (FBIOP)?
What is the 3-year average ROE for Fortress Biotech, Inc. (FBIOP)?
What is the 5-year average ROE for Fortress Biotech, Inc. (FBIOP)?
How does the current ROE for Fortress Biotech, Inc. (FBIOP) compare to its historical average?